Horizon Investments LLC Acquires 165 Shares of Colgate-Palmolive (NYSE:CL)

Horizon Investments LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 1.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,390 shares of the company’s stock after purchasing an additional 165 shares during the period. Horizon Investments LLC’s holdings in Colgate-Palmolive were worth $1,120,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the business. Diamond Hill Capital Management Inc. acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $348,718,000. FMR LLC increased its holdings in Colgate-Palmolive by 65.6% during the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after purchasing an additional 2,674,807 shares in the last quarter. AMF Tjanstepension AB raised its stake in shares of Colgate-Palmolive by 1,088.8% in the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company’s stock valued at $233,584,000 after purchasing an additional 2,353,268 shares during the period. Barclays PLC lifted its holdings in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. Finally, State Street Corp boosted its position in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the period. 80.41% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have commented on CL shares. Wells Fargo & Company cut their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Barclays cut their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday, March 14th. TD Cowen reduced their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, Raymond James reaffirmed an “outperform” rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $101.72.

Colgate-Palmolive Trading Up 1.1 %

CL stock opened at $90.44 on Thursday. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The stock has a market cap of $73.39 billion, a price-to-earnings ratio of 25.69, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a fifty day moving average price of $89.19 and a two-hundred day moving average price of $94.41. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the business posted $0.87 earnings per share. Equities analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.